2025-04-25
CoreMesh has officially launched its global ecosystem roadmap, positioning itself as the world’s first decentralized high-performance computing (HPC) network tailored for AI, Web3, and next-gen digital economies.
The goal? To turn every connected device into a valuable contributor to the global computing grid.
From GPUs to mobile devices, CoreMesh enables anyone to share spare computing power and earn CMT tokens, creating a sustainable and community-owned computing infrastructure. In doing so, it unlocks the backbone for a smarter, faster, and decentralized digital world.
The rise of AI and decentralized applications has created a massive demand for computing power. Yet access to this power is still expensive, centralized, and geographically limited. CoreMesh solves this by distributing workloads across a global network of permissionless nodes—reducing cost, boosting efficiency, and enhancing resilience.
With SMART Chain as its foundational blockchain, CoreMesh ensures speed, security, and scalability. Its DAO model empowers token holders to vote on upgrades, partnerships, and resource allocations—putting the community at the heart of every decision.
The recent launch of the CMT token marks a major milestone. It unlocks the full economic engine behind CoreMesh, powering task execution, staking, and incentivizing node participation. The token is now live on select exchanges and integrated into the official DApp.
In a world demanding ever more intelligence, decentralization, and speed, CoreMesh is not just timely—it’s necessary. Welcome to the era of community-powered computation.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map